We've now been living with COVID for well over four years. Although there's still much to learn about SARS-CoV-2 (the virus that causes COVID) at least one thing seems clear: it's here to stay.
May 25, 2024
0
53
New research from scientists at La Jolla Institute for Immunology (LJI) suggests people who received COVID-19 vaccines and then experienced "breakthrough" infections are especially well armed against future SARS-CoV-2 infections.
May 24, 2024
0
122
Children who were exposed to SARS-CoV-2 (COVID-19) while in the womb or as newborn babies may face greater difficulties with social skills and have more respiratory symptoms than non-exposed children, according to a new University ...
May 23, 2024
0
0
Since the COVID-19 pandemic, SARS-CoV-2 has caused unexplained, chronic, post-infection symptoms in survivors. The phenomenon, known as post-acute sequelae of SARS-CoV-2 infection or "long COVID," surfaced shortly after COVID-19 ...
May 20, 2024
0
7
The COVID-19 pandemic is over, but the virus that caused it is still here, sending thousands of people to the hospital each week and spinning off new variants with depressing regularity. The virus's exceptional ability to ...
May 18, 2024
2
145
A new study has revealed important insights into how SARS-CoV-2 and its variants escape the immune system. The findings pave the way for new therapeutic approaches against COVID-19.
May 15, 2024
0
28
The blood-retinal barrier is designed to protect our vision from infections by preventing microbial pathogens from reaching the retina where they could trigger an inflammatory response with potential vision loss. But researchers ...
May 14, 2024
0
53
The rapid development of vaccines that protect against COVID was a remarkable scientific achievement that saved millions of lives. The vaccines have demonstrated substantial success in reducing death and serious illness after ...
May 11, 2024
0
74
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer. SARS-CoV-2 spike protein mediates host cell infection and cell-cell fusion that causes ...
May 7, 2024
1
7
A combination of two antiviral compounds may be a promising alternative to Paxlovid when treating COVID-19 in immunocompromised patients, according to Karen S. Anderson, Ph.D., professor of pharmacology and of molecular biophysics ...
Apr 30, 2024
0
121
